Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
January 06 2025 - 4:01PM
Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA)
today announced that it will present at the 43rd Annual J.P. Morgan
Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m.
Pacific Time (4:30 p.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible
through the Investors section of the company’s website at
www.kiniksa.com. A replay of the event will also be available on
Kiniksa’s website within approximately 48 hours after the
event.
About KiniksaKiniksa is a commercial-stage
biopharmaceutical company focused on discovering, acquiring,
developing, and commercializing therapeutic medicines for patients
suffering from debilitating diseases with significant unmet medical
need. Kiniksa’s immune-modulating assets are based on strong
biologic rationale or validated mechanisms, target a spectrum of
underserved cardiovascular and autoimmune conditions, and offer the
potential for differentiation. For more information, please
visit www.kiniksa.com.
Every Second Counts! ®
Kiniksa Investor ContactJonathan Kirshenbaum
(781) 829-3949jkirshenbaum@kiniksa.com
Kiniksa Media ContactTyler Gagnon(781)
431-9100tgagnon@kiniksa.com
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Jan 2025 to Feb 2025
Kiniksa Pharmaceuticals (NASDAQ:KNSA)
Historical Stock Chart
From Feb 2024 to Feb 2025